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Abstract: Efforts to develop metallic zinc for biodegradable implants have significantly advanced
following an earlier focus on magnesium (Mg) and iron (Fe). Mg and Fe base alloys experience
an accelerated corrosion rate and harmful corrosion products, respectively. The corrosion rate
of pure Zn, however, may need to be modified from its reported ~20 µm/year penetration rate,
depending upon the intended application. The present study aimed at evaluating the possibility of
using Fe as a relatively cathodic biocompatible alloying element in zinc that can tune the implant
degradation rate via microgalvanic effects. The selected Zn–1.3wt %Fe alloy composition produced
by gravity casting was examined in vitro and in vivo. The in vitro examination included immersion
tests, potentiodynamic polarization and impedance spectroscopy, all in a simulated physiological
environment (phosphate-buffered saline, PBS) at 37 ◦C. For the in vivo study, two cylindrical disks
(seven millimeters diameter and two millimeters height) were implanted into the back midline of male
Wister rats. The rats were examined post implantation in terms of weight gain and hematological
characteristics, including red blood cell (RBC), hemoglobin (HGB) and white blood cell (WBC) levels.
Following retrieval, specimens were examined for corrosion rate measurements and histological
analysis of subcutaneous tissue in the implant vicinity. In vivo analysis demonstrated that the
Zn–1.3%Fe implant avoided harmful systemic effects. The in vivo and in vitro results indicate that
the Zn–1.3%Fe alloy corrosion rate is significantly increased compared to pure zinc. The relatively
increased degradation of Zn–1.3%Fe was mainly related to microgalvanic effects produced by a
secondary Zn11Fe phase.
Keywords: zinc; bioabsorbable; biodegradable; implants; encapsulation; in vivo
1. Introduction
The development of bioabsorbable metal implants has drawn major attention over the last
two decades. Early studies mainly focused on pure Fe and Mg and their alloys. Bioabsorbable
implants based on Fe exhibit good biocompatibility and excellent mechanical properties [1–5].
However, they suffer from a harmful mode of corrosion that produces a voluminous iron oxide
layer [6]. The steady accumulation of the iron oxide reduces the lumen cross section, compromises
the integrity of the arterial wall by repelling neighboring tissue and cells [7], and stimulates
inflammation [8]. Bioabsorbable implants based on Mg are attractive mainly due to their excellent
biocompatibility [8–20]. Unfortunately, Mg and its alloys exhibit an excessive corrosion rate associated
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with a potentially harmful release of hydrogen gas [15,18]. The challenges faced with both Fe and Mg
systems have motivated a search for new metallic materials, among them Zn and Zn-based alloys.
Early in vivo studies with pure zinc arterial implants have reported a promising
biocompatibility [21,22]. The biodegradation rate is near the projected ideal value for vascular
stents, and between that of Mg and Fe. In addition, Zn has important physiological roles, exerting
strong anti-atherogenic properties [23], participating in nucleic acid metabolism, signal transduction,
apoptosis regulation, and gene expression [24,25]. Zinc is not toxic to the human body at the low
levels expected to be released from a typical stent [26]. Our extensive preliminary observations have
confirmed the lack of overt toxicity at the interface between a zinc implant and biological tissue,
despite even 20 months residence time in the body [21,27–29]. However, at high levels zinc can cause
toxicity, manifested in poor growth and anemia [30,31]. To avoid negative responses, the corrosion
rate for zinc-based implants may need to be optimized for biodegradable application. Our previous
studies demonstrated that the corrosion rate of a Zn implant can be reduced in the first several weeks
after deployment into an arterial environment by manipulating the oxide film characteristics [32] or
adding a polymeric layer [33]. In addition, earlier research carried out by the authors [27] suggested
that the low degradation rate of arterial implants made from pure zinc can provoke a long-term
process of inflammation and fibrous encapsulation. Encapsulation can be considered as a major
factor contributing to implant failure, as it isolates the implant from the surrounding tissue and can
potentially cause a discontinuation of the biodegradation process [34,35]. This was supported by
Yue et al. [36] which indicated that too low degradation rate is a challenge for future application of Zn
base alloys as adequate biodegradable implant.
The need to improve the strength of Zn and Zn-based materials, manipulate their corrosion
rate and improve their biocompatibility motivated the search for new Zn-based alloys [37–51].
In order to obtain a higher corrosion rate without compromising biocompatibility, the alloying element
must be biocompatible and have the potential to increase the corrosion rate of the Zn-based alloy.
Since Fe is known as a biocompatible element and the intermetallic phases formed between Zn and
Fe all have higher electrochemical potential [52,53], it was considered a suitable alloying element.
The present study aimed at exploring the prospects of Zn–1.3wt %Fe (denoted as Zn–1.3%Fe) alloy as
a biodegradable implant material in terms of in vitro and in vivo behavior.
2. Experimental Procedure
Ingots of pure Zn and Zn–1.3%Fe alloy were produced by gravity casting in a rectangular steel die
having the following dimensions: 6 × 25 × 4.5 cm. Prior to the casting process, pure zinc bars (99.99%)
and pure iron (99%) powder (−325 mesh) in the desired amount were placed in a graphite crucible
and heated to 750 ◦C for 3 h in a furnace, with stirring every 30 min. All the test samples produced
from the cast ingot were machined from the central part of the ingot, producing surface roughness
type N5. The chemical compositions of the obtained ingots were determined using an Inductively
Coupled Plasma Optical Emission Spectrometer (ICP-SPECTRO, ARCOS FHS-12, Kelve, Germany)
method, with results shown in Table 1.
Table 1. Chemical composition of pure Zn and Zn–1.3%Fe alloy.
Material System Fe (wt %) Pb (wt %) Al (wt %) Cu (wt %) Cd (wt %)
Pure Zn 0.0054 0.0011 0.0026 0.0007 0.0017
Zn–1.3%Fe 1.31 0.0010 0.0079 0.0006 0.0017
Microstructure examination was carried out using scanning electron microscopy (SEM) with a
JEOL JSM-5600 (JEOL, Tokyo, Japan) equipped with an Energy-dispersive X-ray spectroscopy (EDS)
detector (Thermo Fisher Scientific, Waltham, MA, USA) for spot elemental analysis. Identification
of internal phases was conducted using an X-ray diffractometer RIGAKU-2100H (RIGAKU, Tokyo,
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Japan) with Cu-Kα. The diffraction parameter was 40 kV/30 mA and the scanning rate was 2◦/min.
Indication of mechanical properties was obtained by Vickers hardness measurements performed in a
Zwick/Roell Indentec of Quantarad Technologies, with an applied load of 3 kg. The tensile tests were
performed at room temperature using a universal material test machine (Hounsfield H25KT, Horsham,
PA, USA) at a rate of 0.5mm/min.
The in vitro corrosion behavior was examined by an immersion test for up to 20 days, according
to the ASTM G31-12a standard as well as by electrochemical characterization and stress corrosion
analysis. All the in vitro corrosion tests were carried out in phosphate-buffered saline (PBS) solution at
37 ◦C with pH levels of ~7.4. The selected corrosion medium and environmental conditions aimed at
simulating the natural physiological environment [54–56]. Monitoring of pH levels was conducted by
daily replacement of the PBS solution. The electrochemical characterization included potentiodynamic
polarization analysis and impedance spectroscopy (EIS) using a Bio-Logic SP-200 potentiostat equipped
with EC-Lab software V11.02. The three-electrode cell used for the electrochemical analysis included
a saturated calomel reference electrode (SCE), a platinum counter electrode, and the tested sample
as the working electrode, with an exposure area of 1cm2. The scanning rate of the potentiodynamic
polarization analysis was 1 mV/s; the EIS measurements were carried out between 10 kHz and 100 mHz
at 10 mV amplitude over the open circuit potential. Prior to electrochemical testing, the samples were
cleaned in an ultrasonic bath for 5 min, washed with alcohol, and dried in hot air.
The metals used for the in vivo assessment included pure zinc as the biodegradable reference
material, the Zn–1.3%Fe allow, and titanium alloy Ti–6Al–4V as a biostable reference material.
The implant geometry of cylindrical disks of 7 mm diameter and 2 mm height was obtained by
regular machining from cast Zn base ingots and wrought billet in the case of the titanium ally. Prior to
implantation, the disks were ultrasonically cleaned in ethanol for 5 min and then in acetone for 3 min
before final air drying.
All the animal experiments were approved by the Ben-Gurion University of the Negev (BGU)
Committee for the Ethical Care and Use of Laboratory Animals (BGU-IACUC). The experiments were
performed according to the Israel Animal Welfare law (1994) and the NRC Guide for the Care and Use
of Laboratory Animals (2011). BGU’s animal care and use program is approved by the Association for
the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The in vivo
experiments were carried out in the BGU rodent facility. Nine 250 g male Wistar rats (Envigo, Jerusalem,
Israel) were selected for the in vivo assessment. The rats were divided into 3 groups. The first group
(n = 3) was implanted with pure Zn disks, the second group (n = 3) with the Zn–1.3%Fe alloy, and the
third group (n = 3) with Ti–6Al–4V.
For implantation, the rats were anesthetized with an inhalation anesthesia machine using 3%
isoflurane (Terrel TM Piramal Critical Care, Inc., Bethlehem, PA, USA) in 500 mL/min 100% oxygen.
Two cylindrical disks were implanted aseptically subcutaneously in the midline of the back of the rats,
one between scapulas and another in mid-lumbar area. Post alloy implantation, the rats were placed
on a heating pad until they recovered form anesthesia and were able to ambulate. For postoperative
analgesia, rats received 100 mg/kg Dipyrone (Vitamed Pharmaceutical Industries LTD, Binyamina,
Israel) in the drinking water for 3 days. Rats were monitored daily for surgical wound appearance,
locomotion in the cage, grooming activity and general wellbeing for the first week. This was followed
by a weekly evaluation of body weight, attitude and incision appearance. Blood was collected from
the retro-orbital sinus under isoflurane anesthesia as described above. Whole blood (1 mL) was
collected in EDTA for a complete blood count for red blood cells (RBC), hemoglobin (HGB) and
white blood cells (WBC). Serum (1 mL) was collected for determination of Zn levels. Blood work was
analyzed on the day of implantation and at 4 and 8 weeks post-implantation. The blood biochemical
parameters in terms of RBC, HGB and WBC can indicate abnormal situations, such as a significant
increase in Zn content or infection. At 14 weeks the rats were euthanized with intraperitoneal
150 mg/kg Pentobarbital (CTS Chemical Industries Ltd., Hod Hasharon, Israel) for alloy and tissue
harvest. Tissue from each alloy location was placed in 10% formaldehyde for histology. Removal
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of corrosion products to calculate the corrosion rate was preformed according to ASTM G1 using
10%NH4Cl solution, which allowed for a calculation of the corrosion rate.
The statistical analysis was implemented using a one-way ANOVA to determine the significance
of paired comparisons. A p value < 0.05 was selected for statistical difference between means.
3. Results
The typical microstructure of pure zinc and Zn–1.3%Fe alloy are shown in cross-sectional view
(Figure 1), along with a spot chemical analysis at various points, shown in Table 2. A regular structure
without any second phase is present in pure zinc. The Zn–1.3%Fe alloy contained Zn matrix and an
Fe-rich phase that was dispersed homogenously across the bulk of the alloy. The Fe content within the
Fe-rich phase, as obtained by EDS analysis, was between 7 and 10 wt % corresponding with Fe content
in the Zn-delta phase composition [52].
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Figure 1. Microstructure at cross-section of (a) Pure Zn. (b,c) Zn–1.3%Fe alloy, macro and close-up
view respectively.
Table 2. Chemical composition of Zn–1.3%Fe at different points shown in Figure 1b.
El Element (wt %) Tested Area Zn Fe
Point 1 90 ± 1 9.8 ± 0.3
Point 2 100 ± 1 0.13 ± 0.08
The X- ay diffraction analysis (Figure 2) revealed the prese ce of the two majo phases: a pure
Zn and Fe rich phase. Additional precipitating phases in the Zn–1.3%Fe alloy appear to be Delta Zn
(ICDD 045-1184), with a possible contribution of Zeta Zn. This result is in accordance with the EDS
analysis of the Fe-rich phase.
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Figure 2. X-ray diffraction analysis of pure Zn and Zn–1.3%Fe alloy.
Hardness tests were conducted to begin evaluating the mechanical properties. The hardness of
pure Zn and Zn–1.3%Fe alloy were 40 ± 3 and 56 ± 2 HV (hardness Vickers), respectively. The increased
Zn–1.3%Fe alloy hardness is attributed to the additional Delta Zn phase.
The mechanical properties of pure Zn and Zn–1.3%Fe alloy in as-cast conditions are shown in
Figure 3. While the yield strength (YS) and ultimate tensile strength (UTS) of Zn–1.3%Fe alloy was
improved compared to pure Zn, the ductility was relatively reduced.
Metals 2018, 8, x FOR PEER REVIEW  5 of 15 
 
 
Figure 2. X-ray diffraction analysis of pure Zn and Zn–1.3Fe alloy. 
Hard ess tests were conducted to begin evaluating the mechanical pro r es. The hardn s  of
pure Zn and Zn–1.3Fe alloy were 40 ± 3 and 56 ± 2 HV (hardness Vick rs), respectively. The increased 
Zn–1.3Fe alloy hardness is attributed to the additio al Delta Zn phase.  
The mechanical properties of pure Zn and Zn–1.3Fe alloy i  as-cast conditions ar  sh wn in
Figure 3. While the yield stre g  (YS) and ultimate tensile strength (UTS) of Zn–1.3Fe alloy was 
improved compared to pure Zn, the ductility was relatively reduced.  
 
Figure 3. Mechanical properties of pure Zn and Zn–1.3Fe. 
Close-up views f the external surfac s of pu e Zn and Zn–1.3Fe alloy after immersion tests of
10 and 20 days are shown i  Figure 4. While a general cor osion attack was observed in both samples,
it was significa tly more int nse in the Zn–1.3Fe alloy for both exposure times. The corrosion attack
against pure Zn was relatively mil and di not cover the entire s mple surface, the attack against 
Zn–1.3Fe al oy was m re evere and covered the e tire sampl surface. 
Th calculated cor osion rates f r pu e Zn and Zn–1.3Fe a loy, obtained by e imme sio
tests, are shown in Figure 5. The corrosion rate of the Zn–1.3Fe alloy was nearly twice that of pure Zn 
after 10 and 20 days of exposure.  
Figure 3. Mechanical properties of pure Zn and Zn–1.3%Fe.
Close-up views of the external surfaces of pure Zn and Zn–1.3%Fe alloy after immersion tests of
10 and 20 days are shown in Figure 4. While a general corrosion attack was observed in both samples,
it was significantly more intense in the Zn–1.3%Fe alloy for both exposure times. The corrosion attack
against pure Zn was relatively mild and did not cover the entire sample surface, the attack against
Zn–1.3%Fe alloy was more severe and covered the entire sample surface.
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The calculated corrosion rates for pure Zn and Zn–1.3%Fe alloy, as obtained by the immersion
tests, are shown in Figure 5. The corrosion rate of the Zn–1.3%Fe alloy was nearly twice that of pure
Zn after 10 and 20 days of exposure.Metals 2018, 8, x FOR PEER REVIEW  6 of 15 
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Figure 4. Optical microscopy showing corrosion attack at the surface of pure Zn and Zn–1.3%Fe alloy
after immersion tests in phosphate-buffered saline (PBS) solution at 37 ◦C. (a,b) pure Zn and Zn–1.3%Fe
alloy after 10 days of exposure. (c,d) pure Zn and Zn–1.3%Fe alloy after 20 days of exposure.
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Figure 5. Corrosion rate measurements of pure Zn and Zn–1.3%Fe alloy after immersion tests in PBS
solution at 37 ◦C.
In order to further investigate the corrosion attack mechanism in Zn–1.3%Fe alloy, close- p cross
sectional views of the corroded area were inspected, as shown in Figure 6. The images revealed a
uniform corrosion attack at the external surface (Figure 6a). This phenomenon is in line with the basic
degradation requirements of biodegradable implants in terms of preserving their mechanical integrity
during the critical period after implantation and undergoing degradation without risk of premature
implant fracture during the mechanical scaffolding phase. At higher magnification (Figure 6b),
intact Zn11Fe particles are seen in the vicinity of corroded matrix. In accordance with our hypothesis,
the cathodic Zn11Fe particles (−0.87 Vsce vs. −1.03 Vsce for pure Zn [53]) acted as a cathodic phase
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to the Zn matrix, causing accelerated degradation by micro-galvanic effect. This mechanism can
explain the higher corrosion rate of the Zn–1.3%Fe alloy compared to pure Zn as quantified by the
immersion test.Metals 2018, 8, x FOR PEER REVIEW  7 of 15 
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Figure 6. Surface cross section showing corrosion attack of Zn–1.3%Fe alloy after 10 days of exposure:
(a) Macro view. (b) Close-up view.
The electrochemical analysis by potentiodynamic polarization is shown in Figure 7, and the
corresponding Tafel extrapolation measurements are listed in Table 3. The polarization curve of
the Zn–1.3%Fe alloy shifted to higher current densities compared to pure Zn, indicating a reduced
corrosion resistance. Tafel extrapolation obtained from the polarization curves support this observation,
identifying a corrosion rate of 0.013 millimeter per year (mm/y) for Zn–1.3%Fe compared to
0.010 mm/y for the pure Zn sample.
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Figure 7. Potenti dynamic polar zat on curves obtained in PBS solution.
Table 3. Corrosion potential (Ec rr), corrosion current (Icorr) and corrosion rate (C.R.) obtained by Tafel
extrapolation from polarization curves shown in Figure 7.
C.R (mm/y) Icorr (µA/cm2) Ecorr (V) Parameter Specimen C.R ( m/y)
0.0 0 0.67 −1.02 Pure Zn 0.010
0.013 0.89 −1.04 Zn–1.3%Fe 0.013
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The impedance spectroscopy analysis in terms of impedance modifications after immersion times
of 1 and 48 h in PBS solution are shown by Nyquist plots in Figure 8 and Bode plots in Figure 9.
The relatively larger radius of curvature in the Nyquist diagram of the pure Zn sample indicates that
its corrosion resistance was significantly increased compared to the Zn–1.3%Fe sample. Bode diagrams
reveal that after one hour of exposure to the PBS solution, the corrosion resistance of both samples
are nearly the same (around 10,000 Ohm), while after 48 h of exposure the corrosion resistance of
the Zn–1.3%Fe sample decreased from about 8130 Ohm to 4365 Ohm. The results obtained by the
potentiodynamic polarization and impedance spectroscopy analysis are in accordance with the results
from the immersion tests.
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The in vivo evaluation demonstrated a normal weight gain for all the rats irrespective of implant
type Zn, Figure 10. Post-implantation behavior, cage locomotion and surgical wound appearance were
all normal, with no signs of compromised health.
Zinc serum levels and blood biochemical parameters (RBC, HGB and WBC) examined before and
after implantation are shown in Figures 11–14. The Zn content was slightly increased in the case of
pure Zn and Zn–1.3%Fe implantations compared to titanium, as expected, but in all cases was within
the normal range of 168–190 [µg/dL] [57]. Furthermore, none of the implanted samples exerted a
negative effect on the hematological profiles of the rats, as all of the measurements were within the
normal range [58]: RBC 7.62–9.99 [106/µL], HGB 13.6–17.4 [g/dL], WBC 1.98–11.06 [103/µL].
The corrosion rate of pure Zn and Zn–1.3%Fe implants at 14 weeks post implantation are shown
in Figure 15. The corrosion rate of Zn–1.3%Fe was significantly increased relative to pure Zn.
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Figure 15. Corrosion rate of pure Zn and Zn–1.3%Fe implants after 14 weeks of implantation.
Histology analyses of the subcutaneous tissue around the tested implants (pure Zn, Zn–1.3%Fe
and Ti–6Al–4V as reference alloy) at 14 weeks post-implantation are shown in Figure 16. None of
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the zinc-bearing implants promoted a negative effect on the live tissue or provoked an inflammatory
response compared to the reference Ti alloy.Metals 2018, 8, x FOR PEER REVIEW  11 of 15 
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4. Discussion
Biodegradable implants that strongly resist corrosion in physiological environments may elicit
negative inflammatory responses, as macrophages increase their activity to metabolize foreign
material [27]. Indeed, earlier in vivo work with zinc vascular implants demonstrated that the
corrosion rate may be a critical regulator of inflammation [27]. In this work, we were surprised
to find that the highest purity zinc implant (~0.01 wt % impurities) produced the strongest negative
inflammatory response, and introductions of mainly iron impurities of ~0.3 wt % into the implant
substantially ameliorated the inflammatory response. This discovery raised the intriguing prospect
that inflammatory responses to zinc implants could be controlled by the implant’s corrosion behavior.
In the present proof of concept work, we intended to develop a zinc alloy system that imparts
tunable corrosion rates (by adjusting alloying element concentration) in order to regulate inflammatory
responses. Herein, we have developed such an implant material as well as characterized the effects
of alloying on material properties. The ultimate goal, not pursued in the present study, is to
identify an optimal corrosion rate for avoiding harmful inflammation when deploying zinc based
medical implants.
Several methods can be used to increase the corrosion rate of pure zinc. These methods
include surface film modification, coatings, microstructure manipulation via thermal and mechanical
processing, and alloying. The intent of the present study was to use the biocompatible alloying element
Fe to produce micro-galvanic effects to increase the corrosion rate of pure zinc. This approach was also
adopted by other researchers, for instance in Zn–Cu base systems such as Zn–Cu, by Niu et al. [40],
Zn–Cu–Mg by Tang et al. [44] and Zn–3Cu by Yue et al. [36]. The use of Cu as an alloying
element to produce a micro-galvanic effect was justified by the higher standard potential of Cu
(0.337 V compared to –0.763 V for Zinc) as well as the micro-galvanic effects generated by a secondary
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phase CuZn5. The potential to achieve a micro-galvanic effect in the present study is based on the
elevated electrochemical potential of all Zn–Fe precipitate phases relative to pure zinc. The potentials of
Zn–Fe phases as identified by Lee et al. [53] are as follows (vs. SCE): Delta phase −0.822 V, Zeta phase
−0.940 V, Gamma phase −0.772 V, while pure zinc is −1.03 V.
In-vitro examination of the gravity cast Zn–1.3%Fe alloy demonstrated a nearly 100% increase
in corrosion rate compared to pure zinc. This was supported by the electrochemical analysis in
terms of potentiodynamic polarization and impedance examination as well as the in vivo corrosion
rate measurements at 14 weeks post implantation. The mechanical properties of pure zinc in as
cast conditions obtained by this study are in line with the reported results of Gong et al. [37],
and Li et al. [39]. The increased strength of Zn–1.3%Fe with concomitant reduction in ductility is
attributed to the effect of Fe as an alloying element. Nevertheless, the strength and ductility of
Zn–1.3%Fe alloy in the as cast condition are still relatively low. In order to improve these properties,
additional metal forming processing, such as hot extrusion [59], are required to obtain an adequate
structural material for practical degradable implant applications.
The in vivo study demonstrated that the pure Zn and Zn–1.3%Fe alloy avoided negative systemic
effects on the wellbeing behavior and normal growth of the rats during the 12 weeks of implantation.
Furthermore, the implantation of these two materials did not increase the amount of zinc in blood
beyond the acceptable level. This was supported by the absence of anemia in terms of RBC and
HGB levels. In addition, there were no signs of infection following implantation of either Zn base
system, as there was no increase in the amount of white blood cells (WBC). This was confirmed by
the histology analyses of subcutaneous tissue in the vicinity of the tested Zn base implants. Although
not performed directly at the implant-tissue interface, the histology shows a general absence of
harmful effects at 14 weeks post implantation from the implant or corrosion activity. The corrosion
rate of pure Zn and Zn–1.3%Fe alloy under in vivo conditions was relatively reduced compared to
their corrosion rate under in vitro conditions. This result is in accordance with the observations
of Torne et al. [56], and Witte et al. [60] who have reported that the aggressiveness of the in vivo
physiological environment towards the biodegradable metal implants is relatively lower compared to
the in vitro submersion of metals under PBS solution. Further contributing to the disparity, the two
cylindrical disks implanted in the midline of the back of the rats were exposed to a relatively low blood
flow that practically generates a relatively reduced corrosion attack compared to the in vitro conditions.
Together, the results of the present study indicate that Zn–1.3%Fe alloy can significantly increase
the corrosion rate of pure Zn. Consequently, this alloy can overcome the inherent low degradation rate
of pure Zn and can be considered as a potential structural material candidate for biodegradable Zn
base implants.
5. Conclusions
Alloying of Zn with Fe at a concentration of 1.3 wt % nearly doubled the corrosion rate in in vitro
and in vivo conditions. The relatively higher corrosion of Zn–1.3%Fe is attributed to the microgalvanic
effect generated mainly by the formation of Delta phase (Zn11Fe). The absence of undesirable systemic
effects, including weight growth, wellbeing activities and hematological characteristics (RBC, HGB
and WBC) of the rats during 14 weeks of implantation, as well as obtaining adequate histology results
in subcutaneous tissue close to the tested implants suggests that the Zn–1.3%Fe alloy can be considered
as a potential material for biodegradable implants.
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